349 related articles for article (PubMed ID: 35296074)
21. Role of the multifunctional DNA repair and redox signaling protein Ape1/Ref-1 in cancer and endothelial cells: small-molecule inhibition of the redox function of Ape1.
Luo M; Delaplane S; Jiang A; Reed A; He Y; Fishel M; Nyland RL; Borch RF; Qiao X; Georgiadis MM; Kelley MR
Antioxid Redox Signal; 2008 Nov; 10(11):1853-67. PubMed ID: 18627350
[TBL] [Abstract][Full Text] [Related]
22. Oxidative stress alters base excision repair pathway and increases apoptotic response in apurinic/apyrimidinic endonuclease 1/redox factor-1 haploinsufficient mice.
Unnikrishnan A; Raffoul JJ; Patel HV; Prychitko TM; Anyangwe N; Meira LB; Friedberg EC; Cabelof DC; Heydari AR
Free Radic Biol Med; 2009 Jun; 46(11):1488-99. PubMed ID: 19268524
[TBL] [Abstract][Full Text] [Related]
23. Methods to Assess Oxidative DNA Base Damage Repair of Apurinic/Apyrimidinic (AP) Sites Using Radioactive and Nonradioactive Oligonucleotide-Based Assays.
Gupta KB; Kaur S; Dhiman M; Mantha AK
Methods Mol Biol; 2022; 2413():155-163. PubMed ID: 35044663
[TBL] [Abstract][Full Text] [Related]
24. DNA repair and redox activities and inhibitors of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1): a comparative analysis and their scope and limitations toward anticancer drug development.
Kaur G; Cholia RP; Mantha AK; Kumar R
J Med Chem; 2014 Dec; 57(24):10241-56. PubMed ID: 25280182
[TBL] [Abstract][Full Text] [Related]
25. The role of the N-terminal domain of human apurinic/apyrimidinic endonuclease 1, APE1, in DNA glycosylase stimulation.
Kladova OA; Bazlekowa-Karaban M; Baconnais S; Piétrement O; Ishchenko AA; Matkarimov BT; Iakovlev DA; Vasenko A; Fedorova OS; Le Cam E; Tudek B; Kuznetsov NA; Saparbaev M
DNA Repair (Amst); 2018 Apr; 64():10-25. PubMed ID: 29475157
[TBL] [Abstract][Full Text] [Related]
26. Regulation of HIF1α under Hypoxia by APE1/Ref-1 Impacts CA9 Expression: Dual Targeting in Patient-Derived 3D Pancreatic Cancer Models.
Logsdon DP; Grimard M; Luo M; Shahda S; Jiang Y; Tong Y; Yu Z; Zyromski N; Schipani E; Carta F; Supuran CT; Korc M; Ivan M; Kelley MR; Fishel ML
Mol Cancer Ther; 2016 Nov; 15(11):2722-2732. PubMed ID: 27535970
[TBL] [Abstract][Full Text] [Related]
27. Apurinic/Apyrimidinic Endonuclease 1/Redox Factor-1 (Ape1/Ref-1) Modulates Antigen Presenting Cell-mediated T Helper Cell Type 1 Responses.
Akhter N; Takeda Y; Nara H; Araki A; Ishii N; Asao N; Asao H
J Biol Chem; 2016 Nov; 291(45):23672-23680. PubMed ID: 27637330
[TBL] [Abstract][Full Text] [Related]
28. Redox regulation of the DNA repair function of the human AP endonuclease Ape1/ref-1.
Kelley MR; Parsons SH
Antioxid Redox Signal; 2001 Aug; 3(4):671-83. PubMed ID: 11554453
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of APE1/Ref-1 redox activity rescues human retinal pigment epithelial cells from oxidative stress and reduces choroidal neovascularization.
Li Y; Liu X; Zhou T; Kelley MR; Edwards P; Gao H; Qiao X
Redox Biol; 2014; 2():485-94. PubMed ID: 24624338
[TBL] [Abstract][Full Text] [Related]
30. APE1/Ref-1 as a Therapeutic Target for Inflammatory Bowel Disease.
Sahakian L; Robinson AM; Sahakian L; Stavely R; Kelley MR; Nurgali K
Biomolecules; 2023 Oct; 13(11):. PubMed ID: 38002251
[TBL] [Abstract][Full Text] [Related]
31. Functional analysis of the involvement of apurinic/apyrimidinic endonuclease 1 in the resistance to melphalan in multiple myeloma.
Xie J; Zhang L; Li M; Du J; Zhou L; Yang S; Zeng L; Li Z; Wang G; Wang D
BMC Cancer; 2014 Jan; 14():11. PubMed ID: 24400589
[TBL] [Abstract][Full Text] [Related]
32. Antitumor Activity and Mechanistic Characterization of APE1/Ref-1 Inhibitors in Bladder Cancer.
Fishel ML; Xia H; McGeown J; McIlwain DW; Elbanna M; Craft AA; Kaimakliotis HZ; Sandusky GE; Zhang C; Pili R; Kelley MR; Jerde TJ
Mol Cancer Ther; 2019 Nov; 18(11):1947-1960. PubMed ID: 31413178
[TBL] [Abstract][Full Text] [Related]
33. Going APE over ref-1.
Evans AR; Limp-Foster M; Kelley MR
Mutat Res; 2000 Oct; 461(2):83-108. PubMed ID: 11018583
[TBL] [Abstract][Full Text] [Related]
34. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor.
Zhang Y; Wang J; Xiang D; Wang D; Xin X
Int J Oncol; 2009 Nov; 35(5):1069-79. PubMed ID: 19787261
[TBL] [Abstract][Full Text] [Related]
35. Altered expression of Ape1/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation.
Robertson KA; Bullock HA; Xu Y; Tritt R; Zimmerman E; Ulbright TM; Foster RS; Einhorn LH; Kelley MR
Cancer Res; 2001 Mar; 61(5):2220-5. PubMed ID: 11280790
[TBL] [Abstract][Full Text] [Related]
36. APE1/Ref-1 regulates STAT3 transcriptional activity and APE1/Ref-1-STAT3 dual-targeting effectively inhibits pancreatic cancer cell survival.
Cardoso AA; Jiang Y; Luo M; Reed AM; Shahda S; He Y; Maitra A; Kelley MR; Fishel ML
PLoS One; 2012; 7(10):e47462. PubMed ID: 23094050
[TBL] [Abstract][Full Text] [Related]
37. Blocking HIF signaling via novel inhibitors of CA9 and APE1/Ref-1 dramatically affects pancreatic cancer cell survival.
Logsdon DP; Shah F; Carta F; Supuran CT; Kamocka M; Jacobsen MH; Sandusky GE; Kelley MR; Fishel ML
Sci Rep; 2018 Sep; 8(1):13759. PubMed ID: 30214007
[TBL] [Abstract][Full Text] [Related]
38. Dynamic Regulation of APE1/Ref-1 as a Therapeutic Target Protein.
Choi S; Joo HK; Jeon BH
Chonnam Med J; 2016 May; 52(2):75-80. PubMed ID: 27231670
[TBL] [Abstract][Full Text] [Related]
39. Apurinic/apyrimidinic endonuclease 1 is a key modulator of keratinocyte inflammatory responses.
Lee HM; Yuk JM; Shin DM; Yang CS; Kim KK; Choi DK; Liang ZL; Kim JM; Jeon BH; Kim CD; Lee JH; Jo EK
J Immunol; 2009 Nov; 183(10):6839-48. PubMed ID: 19846872
[TBL] [Abstract][Full Text] [Related]
40. The many functions of APE1/Ref-1: not only a DNA repair enzyme.
Tell G; Quadrifoglio F; Tiribelli C; Kelley MR
Antioxid Redox Signal; 2009 Mar; 11(3):601-20. PubMed ID: 18976116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
